Delivery Order SPE2DB25D3110-SPE2DB25FTELC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,808.52 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Airsupra 90-80 microgram inhaler units (10.7 grams). This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,894.52 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Airsupra 90-80 micrograms inhaler in 10.7-gram units. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,328.03 firm fixed price delivery order for AIRSUPRA 90-80 MCG Inhaler 10.7GM on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive contract will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Airsupra 90-80 mcg inhalers (10.7 gm units) with a ceiling value of $2,627.78. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. As a child contract, this order draws from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.00 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This competitively awarded, firm fixed-price contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Airsupra 90-80 microgram inhalers (10.7 grams) with a ceiling value of $3,441.57. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $3,734.64 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhalator (10.7gm) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded contract with firm fixed pricing carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,939.08 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhaler (10.7 grams) on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed price contract represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,244.88 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhaler (10.7 grams), with an ultimate completion date of May 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,023.20 delivery order on September 16, 2025, for Airsupra 90-80 mcg inhaler 10.7gm pharmaceutical supplies to support federal medical procurement needs. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTELCDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,584.23 on September 17, 2025, for the supply of Airsupra 90-80 micrograms inhaler in 10.7-gram units. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that serves as the primary pharmaceutical support mechanism for military healthcare programs globally. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of delivery orders for pharmaceutical products and medical supplies across multiple therapeutic domains, demonstrating consistent capability to meet federal procurement requirements through open competition. This specific delivery order for respiratory medication aligns with the broader DLA Troop Support Medical supply mission to ensure adequate pharmaceutical inventories supporting military personnel and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/17/25 |